Edward Miller's Net Worth
$1.18 Million
Who is Edward Miller?
Edward Miller has an estimated net worth of $1.18 Million. This is based on reported shares across multiple companies, which include Allovir, Inc., and ALEXION PHARMACEUTICALS INC.
SEC CIK
Edward Miller's CIK is 0001619252
Past Insider Trading and Trends
2022 was Edward Miller's most active year for acquiring shares with 6 total transactions. Edward Miller's most active month to acquire stocks was the month of January. 2016 was Edward Miller's most active year for disposing of shares, totalling 7 transactions. Edward Miller's most active month to dispose stocks was the month of January. 2016 saw Edward Miller paying a total of $2,943,360.00 for 32,802 shares, this is the most they've acquired in one year. In 2021 Edward Miller cashed out on 6,000 shares for a total of $232,699.40, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Allovir, Inc. (ALVR) Snapshot price: $0.69
General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.04% | -2.31K |
$0.80 | -$1,839.56 | 220.92K |
May 3
| |||
Form 4
| -0.62% | -1.38K |
$0.75 | -$1,037.63 | 223.23K |
Apr 19 - Apr 22
| |||
Form 4
| -0.16% | -368.00 |
$0.77 | -$284.10 | 224.61K |
Apr 2
| |||
Form 4
| -0.17% | -385.00 |
$0.70 | -$267.65 | 224.98K |
Feb 20
| |||
Form 4
| -3.79% | -8.87K |
$0.67 | -$5,942.23 | 225.36K |
Feb 5
| |||
Form 4
| -0.55% | -1.30K |
$0.67 | -$873.38 | 234.23K |
Jan 23
| |||
Form 4
| -0.18% | -424.00 |
$0.64 | -$270.94 | 235.53K |
Jan 4
| |||
Form 4
| +58.94% | 87.5K |
—
|
—
| 235.96K |
Feb 2
| |||
Form 4
| -0.58% | -2.57K |
$5.09 | -$13,100.68 | 437.26K |
Scheduled
|
Dec 2 - Jan 20
| ||
Form 4
| -1.22% | -2.36K |
$8.91 | -$21,018.03 | 190.45K |
Scheduled
|
Nov 14
| ||
Form 4/A
| -0.22% | -553.00 |
$9.36 | -$5,176.47 | 249.38K |
Oct 20
| |||
Form 4
| -0.22% | -553.00 |
$9.36 | -$5,176.47 | 249.38K |
Oct 19
| |||
Form 4
| +6.38% | 15K |
—
|
—
| 249.93K |
Aug 16
| |||
Form 4
| +6.34% | 14K |
—
|
—
| 234.93K |
Jul 1
| |||
Form 4
| +11.98% | 23.26K |
—
|
—
| 217.31K |
Jan 18
| |||
Form 4
| -3.02% | -6.00K |
$38.78 | -$232,699.40 | 192.81K |
Scheduled
|
Mar 1
| ||
Form 4
| +7.67% | 28K |
—
|
—
| 392.86K |
Dec 1 - Jan 19
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 32.76K |
—
|
—
| 32.76K |
Aug 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALEXION PHARMACEUTICALS INC No price found
SVP, Chief Compliance Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +24.62% | 3.81K |
$131.48 | -$77,573.00 | 19.28K |
Feb 27 - Feb 28
| |||
Form 4
| -6.33% | -1.04K |
$125.70 | -$131,357.39 | 15.47K |
Feb 6
| |||
Form 4
| -2.17% | -367.00 |
$128.32 | -$47,093.44 | 16.52K |
Sep 9
| |||
Form 4
| +18.79% | 2.67K |
$138.91 | -$45,701.39 | 16.89K |
Feb 26 - Feb 29
| |||
Form 4
| +119.91% | 7.75K |
$143.02 | -$150,313.56 | 14.21K |
Feb 4 - Feb 5
| |||
Form 4
| -5.36% | -366.00 |
$179.55 | -$65,715.30 | 6.46K |
Sep 9
| |||
Form 4
| +127.67% | 3.83K |
—
|
—
| 6.83K |
Feb 27
| |||
Form 4
|
∞
| 3K |
—
|
—
| 3K |
Sep 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||